A series of {4-[4-(6-substituted-benzothiazol-2-yl-amino)-3-carboxy-benzyl]-2-carboxyphenyl}-6-substituted-benzothiazol-2-yl-amines have been synthesized by oxidative cyclization of 1-{4-[4-(3-aryl thiocarbamido)-3-carboxy-benzyl]-2-carboxy-phenyl}-3-aryl thiocarbamides using the solution of bromine in chloroform followed by the basification with dilute ammonium hydroxide solution. Initially 1-{4-[4-(3-aryl thiocarbamido)-3-carboxy-benzyl]-2-carboxy-phenyl}-3-aryl thiocarbamides were prepared by the interaction of different aryl isothiocyanates with 4,4'-methylenebis-(anthranilic acid). The latter was obtained by treating the mixture of anthranilic acid and concentrated hydrochloric acid with 3% aqueous formaldehyde followed by neutralization with sodium hydroxide. The acetylation of bis-benzothiazoles afforded di-acetyl derivatives. The structures of synthesized compounds have been established on the basis of chemical transformation, elemental analysis, equivalent weight determination and IR, 1 H NMR spectral studies. The title compounds have been assayed for their biological activity against gram-positive as well as gramnegative microorganisms.
Introduction
During this decade there has been considerable interest in the synthesis of substituted or fused benzothiazoles, because benzothiazole motif is an important skeleton in naturally occurring biologically active compounds. In addition to this, benzothiazole is having potent biological properties such as antitumor 1, 2 , antimicrobial 3, 4 and LTD 4 receptor antagonist like orexin 5 . Benzothiazole derivatives exhibit antifungal 6, 7 , anti-inflammatory 8, 9 , antitubercular 10 and muscle relaxant 11 activities. Numbers of benzothiazole are known for their manifold medicinal property particularly as antibacterial agents 12, 13 . Benzothiazole derivatives are also used as vasodilator 14 and schistosomicidal agents 15 . Benzothiazoles are the most active heterocyclic compounds having wide range of pharmacological activities. The literature survey reveals the various substituted benzothiazoles possessing wide spectrum of therapeutic activities 16, 17 . Aryl benzothiazoles bearing a substituent at C 2 are of great interest as these structural frame works have proved to be important class of bicylic privileged sub-
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structures owing to their utility as imaging agents for β-amyloid, chemiluminescent agents, anti-tumour agents, calcium channel antagonists, antituberculosis, antiparasitics and also as photosensitizers 5, 18 . In view of these observations about the utility of fused heterocyclic compounds in different fields and as a part of wider programme to provide alternative routes for the synthesis of heterocyclic compounds, we report herein the synthesis of substituted bis-benzothiazole systems using reagents N-aryl isothiocyanates followed by the oxidative cyclization using bromine in chloroform.
Experimental
The melting points of all synthesized compounds were recorded using hot paraffin-bath and are uncorrected. Chemicals used were of AR grade.
1 H-NMR spectra were recorded with TMS as internal standard using CDCl 3 and DMSO-d 6 as solvents. IR spectra were recorded on Perkin-Elmer spectrophotometer in the range 4000-400 cm -1 in nujol mull and as KBr pellete. Purity of the compounds was checked on silica gel-G plates by TLC.
Synthesis of 4,4'-methylene-bis-(anthranilic acid) (3)
The parent compound 4,4'-methylene-bis-(anthranilic acid) 3 was prepared by dissolving anthranilic acid 1 (0.01 mole) in distilled water (15 mL) and 36.5% hydrochloric acid (2.5 mL) at 50 0 C. The mixture was then treated with 3% aqueous formaldehyde 2 (3. 
Synthesis of {4-[4-(benzothiazol-2-yl-amino)-3-carboxy-benzyl]-2-carboxy-phenyl}-benzothiazol-2-yl-amine (5a)
A paste of 1-{2-carboxy-4-[3-carboxy-4-(3-phenyl thiocarbamido)-benzyl]-phenyl}-3-phenyl thiocarbamide 4a (1.5 g) was prepared in benzene. To this a solution of bromine in chloroform was added drop by drop with constant stirring. The colour of bromine was initially disappeared. The addition was continued till brown colour of bromine persisted. 
Synthesis of {4-[4-(benzothiazol-2-yl-acetamido)-3-carboxy-benzyl]-2-carboxy-phenyl} -benzothiazol-2-yl-acetamide (6a)
A mixture of {4-[4-(benzothiazol-2-yl-amino)-3-carboxy-benzyl]-2-carboxy-phenyl}-benzothiazol-2-yl-amine 5a (0.01 mole) and acetic anhydride (0.02 mole) in glacial acetic acid (15 mL) was refluxed for 2 h. The reaction mixture was cooled and poured in a little crushed ice with water, a faint yellow coloured solid precipitated was crystallised from aqueous ethanol to give 6a (76%), m.p. 
Results and Discussion
The parent compound 4,4'-methylene-bis-(anthranilic acid) 3 was prepared by dissolving anthranilic acid 1 (0.01 mole) in distilled water (15 mL) and 36.5% hydrochloric acid (2.5 mL) at 50 0 C. The mixture was then treated with 3% aqueous formaldehyde 2 (3.5 mL) at 20 0 C with stirring for 1 h and neutralized with 10% sodium hydroxide. It was transformed into 1-{4-[4-(3-aryl thiocarbamido)-3-carboxy-benzyl]-2-carboxy-phenyl}-3-aryl thiocarbamides 4a-g by condensing it with different aryl isothiocyanates (0.02 mole) in refluxing benzene medium for 1.5 h. The compounds 4a-g were then transformed into {4-[4-(6-substitutedbenzothiazol-2-yl-amino)-3-carboxy-benzyl]-2-carboxy-phenyl}-6-substituted-benzothiazol-2-yl-amines 5a-g by their oxidative cyclization using the solution of bromine in chloroform. The reaction mixtures were left over night at room temperature and separated solids were crystallized by ethanol. These were acidic to litmus and on determination of equivalent weight found to be the {4-[4-(6-substituted-benzothiazol-2-yl-amino)-3-carboxy-benzyl]-2-carboxy-phenyl}-6-substituted-benzothiazol-2-yl-amine hydrobromides. These on basification with dilute ammonium hydroxide solution afforded the free bases 5a-g. Compounds 5a-g on acylation with mixture acetic anhydride and glacial acetic acid afforded di-acetyl derivatives 6a-g (Scheme 1). 
Scheme 1

Antimicrobial screening
The synthesized compounds 5a-g were screened for their antibacterial activity using cup plate diffusion method 19, 20 . The bacterial organisms used included both gram-positive as well 6 CIU mL -1 and each well (diameter 10 mm) was loaded with 0.1 mL of test compound solution (1000 µg mL -1 ) in DMF, so that concentration of each test compound was 100 µg mL -1 . The zones of inhibition were recorded after incubation for 24 h at 37 0 C, using Vernier caliper. Inhibition zone record of the compounds clearly indicated that 5b, 5c and 5d were highly active against E. coli, S. aureus, S. typhi and moderately active against A. aerogenes. Majority of the compounds were found inactive against B. subtilis (Table 1) .
To determine minimum inhibitory concentration (MIC), the serial dilution technique 21 was followed using nutrient broth medium. The MIC values of compounds 5b, 5c and 5d were determined against E. coli, S. aureus and S. typhi, which were found to be 70, 76 and 80 µg mL -1 respectively.
Screening of these compounds 5a-g having the concentration 1%, for antifungal activity using paper disc method 22 showed that 5b, 5c and 5e were highly active against A. niger, whereas other compounds showed low to moderate activity. The zones of inhibition were recorded after incubation for 48 h at 37 0 C ( Table 1) . 
